Abstract
Objective: The aim of this study was to screen for compounds with relatively high inhibitory activity on acetylcholinesterase.
Methods: Classification models for acetylcholinesterase inhibitors based on KNN (1-nearest neighbors), and a quantitative prediction model based on support vector machine regression were used. The interaction of the compounds and receptors was analyzed using the molecular simulation method.
Results: The radial basis kernel function was selected as the kernel function for support vector machine regression, and a total of 19 descriptors were selected to construct the quantitative prediction model.
Keywords: Alzheimer's disease, acetylcholinesterase inhibitor, non-acetylcholinesterase inhibitor, QSAR model, molecular simulation, SVM.
Current Bioinformatics
Title:Virtual Screening of Acetylcholinesterase Inhibitors Based on Machine Learning Combined with Molecule Docking Methods
Volume: 16 Issue: 7
Author(s): Jinyu Yan, Weiguang Huang, Chi Zhang*, Haizhong Huo*Fuxue Chen*
Affiliation:
- Huaxia Eye Hospital of Foshan, Huaxia Eye Hospital Group, Foshan, Guangdong 528000,China
- Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai,China
- School of Life Sciences, Shanghai University, Shanghai,China
Keywords: Alzheimer's disease, acetylcholinesterase inhibitor, non-acetylcholinesterase inhibitor, QSAR model, molecular simulation, SVM.
Abstract:
Objective: The aim of this study was to screen for compounds with relatively high inhibitory activity on acetylcholinesterase.
Methods: Classification models for acetylcholinesterase inhibitors based on KNN (1-nearest neighbors), and a quantitative prediction model based on support vector machine regression were used. The interaction of the compounds and receptors was analyzed using the molecular simulation method.
Results: The radial basis kernel function was selected as the kernel function for support vector machine regression, and a total of 19 descriptors were selected to construct the quantitative prediction model.
Export Options
About this article
Cite this article as:
Yan Jinyu, Huang Weiguang , Zhang Chi *, Huo Haizhong *, Chen Fuxue *, Virtual Screening of Acetylcholinesterase Inhibitors Based on Machine Learning Combined with Molecule Docking Methods, Current Bioinformatics 2021; 16 (7) . https://dx.doi.org/10.2174/1574893615999200719234045
DOI https://dx.doi.org/10.2174/1574893615999200719234045 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Blockade of Insulin-Like Growth Factor Type-1 Receptor with Cixutumumab (IMC-A12): A Novel Approach to Treatment for Multiple Cancers
Current Drug Targets Caffeine Effect on HIFs/VEGF Pathway in Human Glioblastoma Cells Exposed to Hypoxia
Anti-Cancer Agents in Medicinal Chemistry O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results
Current Radiopharmaceuticals Namitecan: a Hydrophilic Camptothecin with a Promising Preclinical Profile
Current Medicinal Chemistry Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions
Current Signal Transduction Therapy Functionalized magnetic nanoparticles for biomedical applications
Current Pharmaceutical Design Application of Glutathione as Anti-Oxidative and Anti-Aging Drugs
Current Drug Metabolism Cell Cycle and Cancer: The G1 Restriction Point and the G1 / S Transition
Current Genomics The Current Role of PET/CT in Radiotherapy Planning
Current Radiopharmaceuticals Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status
Anti-Cancer Agents in Medicinal Chemistry Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy
Current Medicinal Chemistry Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Human ABC Transporters at blood-CNS Interfaces as Determinants of CNS Drug Penetration
Current Pharmaceutical Design Emerging Roles of P2X Receptors in Cancer
Current Medicinal Chemistry ErbB Antagonists Patenting: “Playing Chess with Cancer”
Recent Patents on Biotechnology Editorial (Thematic Issue: Emerging Concepts and Therapeutics Strategies for the Treatment of Brain Tumors)
Anti-Cancer Agents in Medicinal Chemistry 3-Carboranyl Thymidine Analogues (3CTAs) and Other Boronated Nucleosides for Boron Neutron Capture Therapy
Anti-Cancer Agents in Medicinal Chemistry Cyclodextrins and their Derivatives as Carrier Molecules in Drug and Gene Delivery Systems
Current Organic Chemistry Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases
Current Protein & Peptide Science Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates
Anti-Cancer Agents in Medicinal Chemistry